Genmab A S
USPTO Trademark & Patent Filings
Trademark applications and grants for Genmab A S. Genmab A S has 30 trademark applications. The latest application filed is for "FORTYSSIMO"
- Company Aliases
- Genmab A/S
- GENMAB A/S - Copenhagen V DK
- Genmab A/S - Copenhagen V DK
Trademarks Patents
| Patent Application | Date |
|---|---|
| AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER 20220273809 - 17/628382 JANMAAT; Maarten ; et al. | 2022-09-01 |
| DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES 20220265844 - 17/548436 LISBY; Steen ; et al. | 2022-08-25 |
| ANTIBODIES AGAINST HUMAN CD38 20220204636 - 17/550288 DE WEERS; Michel ; et al. | 2022-06-30 |
| POTENCY ASSAYS FOR ANTIBODY DRUG SUBSTANCE BINDING TO AN FC RECEPTOR 20220177585 - 17/349482 GERARDA HAVENITH; Catharina Emanuele ; et al. | 2022-06-09 |
| MONOCLONAL ANTIBODIES AGAINST HER2 20220169738 - 17/369542 DE GOEIJ; Bart ; et al. | 2022-06-02 |
![EXTRA[NOT]ORDINARY](/TM/98192187/mark.png)
| SEC | 0001434265 | GENMAB A/S |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 